1-(3,5-二氯吡啶-4-基)肼 | 153708-69-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 1-(3,5-二氯吡啶-4-基)肼
• 英文名称: 3,5-dichloro-4-hydrazinopyridine
• 英文别名: 3,5-Dichloro-4-hydrazinylpyridine；(3,5-dichloropyridin-4-yl)hydrazine
• CAS: 153708-69-1
• 化学式: C₅H₅Cl₂N₃
• mdl: MFCD00174279
• 分子量: 178.021
• InChiKey: IKQCIXCXRNHCFB-UHFFFAOYSA-N

物化性质

• 熔点：
  113-115°C
• 沸点：
  264.3±40.0 °C(Predicted)
• 密度：
  1.572±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  50.9
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22
• 海关编码：
  2933990090
• 危险品运输编号：
  UN 2811

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-(3,5-Dichloro-4-pyridyl)hydrazine
Synonyms: 3,5-Dichloro-4-hydrazinopyridine

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-(3,5-Dichloro-4-pyridyl)hydrazine
CAS number: 153708-69-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C5H5Cl2N3
Molecular weight: 178

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(3,5-二氯吡啶-4-基)肼 在 盐酸 作用下， 以 乙醇 为溶剂， 反应 49.0h， 生成 1-[1-(3,5-Dichloro-pyridin-4-yl)-5-methyl-1H-pyrazol-4-yl]-3-[4-(3,5-difluoro-phenyl)-piperazin-1-yl]-propan-1-one
  参考文献：
  名称：

  Synthesis and Antitumor Activity of Novel Pyrimidinyl Pyrazole Derivatives. III. Synthesis and Antitumor Activity of 3-Phenylpiperazinyl-1-trans-propenes

  摘要：

  一系列新型的3-[4-苯基-1-哌嗪基]-1-[5-甲基-1-(2-嘧啶基)-4-吡唑基]-1-反式丙烯及其相关化合物被合成，并通过其对几种肿瘤细胞系的体外细胞毒性活性和对某些肿瘤模型的体内抗肿瘤活性进行了评估，这些化合物既可以通过腹腔注射给药，也可以口服给药。具有3-氯吡啶-2-基团（9g）和3-氟-5-取代苯基哌嗪基团（29b、c和e）的化合物在体外测试中显示出显著的细胞毒性。其中，3-氰基-5-氟苯基衍生物（29b）表现出对包括人癌在内的几种肿瘤细胞的强效抗肿瘤活性，且在老鼠中没有引起不良反应。

  DOI：

  10.1248/cpb.53.153
• 作为产物：
  描述：

  3,4,5-三氯吡啶 生成 1-(3,5-二氯吡啶-4-基)肼
  参考文献：
  名称：

  US6169086

  摘要：

  公开号：

文献信息

• [EN] SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE TRIAZOLE SUBSTITUÉS ET UTILISATIONS ASSOCIÉES
  申请人：BAYER PHARMA AG

  公开号：WO2019081302A1

  公开（公告）日：2019-05-02

  The present invention relates to novel substituted 1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.

  本发明涉及新型的取代1,2,4-三唑衍生物，这些化合物的制备方法，包含这些化合物的药物组合物，以及这些化合物或组合物用于治疗和/或预防疾病的使用，特别用于治疗和/或预防肾脏和心血管疾病。
• 신규한 하이드라진 유도체 및 이의 용도
  申请人：Gwangju Institute of Science and Technology 광주과학기술원(319980993815) BRN ▼410-82-07550

  公开号：KR101728898B1

  公开（公告）日：2017-04-21

  본 발명은 다양한 신규 하이드라진 유도체 화합물 및 이들을 유효성분으로 포함하는 P2X 수용체 활성 억제용 조성물에 관한 것이다. 본 발명은 P2X 수용체의 활성과 관련된 다양한 질환, 즉 만성 염증성 질환, 염증성 통증, 신경병성 통증, 자가면역 질환 또는 퇴행성 질환의 예방 또는 치료에 유용하게 이용될 수 있다.

  本发明涉及各种新型羟肼衍生物化合物以及包含它们作为有效成分的用于P2X受体活性抑制的组合物。本发明可用于与P2X受体活性相关的各种疾病，如慢性炎症性疾病、炎症性疼痛、神经病性疼痛、自身免疫疾病或退行性疾病的预防或治疗。
• [EN] PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO<br/>[FR] COMPOSITIONS PESTICIDES ET PROCÉDÉS QUI LEUR SONT ASSOCIÉS
  申请人：DOW AGROSCIENCES LLC

  公开号：WO2013106254A1

  公开（公告）日：2013-07-18

  This document discloses pesticidal compositions comprising molecules having the following formula ("Formula One"): and processes related thereto.

  该文件披露了包含具有以下分子式（“公式一”）的杀虫剂组合物，以及相关的工艺。
• [EN] PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO<br/>[FR] COMPOSITIONS PESTICIDES ET PROCESSUS ASSOCIÉS À CELLES-CI
  申请人：DOW AGROSCIENCES LLC

  公开号：WO2014126580A1

  公开（公告）日：2014-08-21

  This document discloses pesticidal compositions comprising molecules having the following formula ("Formula One"), - Structure- wherein the compositions further comprise one or more of additional pesticidally active components. Also disclosed are processes for applying the pesticidal composition to plants, seeds and to soil where the plants are going to be planted. The inventive pesticidal compositions are effective toward eradicating pests such as BAW, CEW and GPA.

  本文件披露了包含具有以下公式（"公式一"）的分子的杀虫组合物，其中这些组合物进一步包括一种或多种额外的杀虫活性成分。还披露了将杀虫组合物应用于植物、种子和即将种植的土壤的过程。这种创新的杀虫组合物对于根除诸如BAW、CEW和GPA等害虫是有效的。
• PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS
  申请人：Janssen Pharmaceutica NV

  公开号：US20190381019A1

  公开（公告）日：2019-12-19

  Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT 1. Such compounds are represented by Formula (I) as follows: wherein R 1 , R 2 , R 3 , R 4 , R 5 , and G, are defined herein.

  揭示了一种通过调节MALT 1来治疗受影响的疾病、综合征、状况和紊乱的化合物、组合物和方法。这些化合物由以下的化学式（I）代表：其中R1、R2、R3、R4、R5和G在此处被定义。